Suppression of MicroRNA-383 Enhances Therapeutic Potential of Human Bone-Marrow-Derived Mesenchymal Stem Cells in Treating Spinal Cord Injury via GDNF
Background/Aims: Transplantation of bone-marrow-derived mesenchymal stem cells (MSCs) has been used to treat spinal cord injury (SCI) to enhance tissue repair and neural cell regeneration. Glial cell line derived neurotrophic factor (GDNF) is an identified neural growth and survival factor. Here, we...
Main Authors: | Guo-Jun Wei, Gang An, Zuo-Wei Shi, Kai-Fu Wang, Ying Guan, Yan-Song Wang, Bo Han, En-Ming Yu, Peng-Fei Li, Da-Ming Dong, Li-ping Wang, Zhao-wei Teng, De-lai Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-03-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/468057 |
Similar Items
-
Effects of transplanted GDNF gene modified marrow stromal cells on focal cerebral ischemia in rat
by: Yunliang eWang, et al.
Published: (2011-12-01) -
The Expression implication of GDNF in ventral horn and associated remote cortex in rhesus monkeys with hemisected spinal cord injury
by: De-Lu Qiu, et al.
Published: (2016-09-01) -
Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury
by: Anastasiia O. Sosnovtseva, et al.
Published: (2022-01-01) -
The Future of GDNF in Parkinson's Disease
by: Fredric P. Manfredsson, et al.
Published: (2020-12-01) -
The Influence of Neurotrophic Factors BDNF and GDNF Overexpression on the Functional State of Mice and Their Adaptation to Audiogenic Seizures
by: Angelina O. Kustova, et al.
Published: (2022-08-01)